Key result
Long-term survivors of Wilms tumor treated with radiotherapy and chemotherapy had a significantly higher prevalence of hypertension compared to sibling controls (21.6% vs 1.4%, P<0.001).
Why the study?
Does previous treatment with radiotherapy and chemotherapy increase the prevalence of cardiovascular risk factors in long-term survivors of childhood ALL and Wilms tumor compared to sibling controls?
Observational (n=210)
Does previous treatment with radiotherapy and chemotherapy increase the prevalence of cardiovascular risk factors in long-term survivors of childhood ALL and Wilms tumor compared to sibling controls?
Absolute Event Rate: 21.6% vs 1.4%
p-value: p=<0.001
Long-term survivors of childhood ALL and Wilms tumor treated with radiotherapy have an increased prevalence of cardiovascular risk factors compared to sibling controls.
Supports hypertension monitoring in Wilms survivors; leaves open causal mechanisms and prospective validation before practice change.
BACKGROUND: Only a few studies have assessed cardiovascular risk factors (CRFs) in childhood cancer survivors. We determined the prevalence of CRFs in long-term survivors of acute lymphoblastic leukemia (ALL) and Wilms tumor. PROCEDURE: Adult survivors of ALL and Wilms tumor treated with radiotherapy and chemotherapy (RT + CT) or treated with chemotherapy alone (CT) were compared with sibling controls. CRFs (hypertension, diabetes mellitus, hypercholesterolemia, obesity, renal insufficiency) and hormonal deficiencies were assessed in each participant. Multivariate logistic regression analysis was used to evaluate the association between CRFs and treatment. RESULTS: Seventy-nine ALL, 62 Wilms tumor survivors, and 69 control subjects (mean ages 24.5, 25.9, and 26 years, respectively) were enrolled. Mean follow-up time since cancer treatment was 20.8 years. In the Wilms RT + CT group significantly more survivors had hypertension (21.6% vs. 1.4%, P < 0.001) and renal insufficiency (8.1% vs. 0%, P = 0.016) compared to controls. There were also more patients with multiple CRFs in the Wilms RT + CT group (16.2% vs. 2.9% in controls, P = 0.019). Almost 15% of ALL RT + CT survivors had growth hormone deficiency. Hypogonadism was seen in 18.9% of survivors in the Wilms RT + CT group. We observed no significant differences between CT-treated survivors of both malignancies and controls. The adjusted odds ratio for the occurrence of at least one CRF was 2.6 increased for survivors following abdominal radiotherapy. Treatment with CT alone was not associated with the occurrence of multiple CRFs. CONCLUSIONS: Long-term survivors of ALL and Wilms tumor have unfavorable CRFs due to previous RT not CT.
No takes yet. Share an insight, caveat, or question.
Geenen et al. (2010) conducted an observational in Acute lymphoblastic leukemia and Wilms tumor (n=210). Radiotherapy and chemotherapy vs. Chemotherapy alone or sibling controls was evaluated on Hypertension (p=<0.001). Long-term survivors of Wilms tumor treated with radiotherapy and chemotherapy had a significantly higher prevalence of hypertension compared to sibling controls (21.6% vs 1.4%, P<0.001).